RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

ADR (GMAB) stock saw a modest uptick, ending the day at $19.85 which represents a slight increase of $0.27 or 1.38% from the prior close of $19.58. The stock opened at $19.5 and touched a low of $19.34 during the day,

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his tenure.

In a report released today, Sebastian Kuenne from RBC Capital maintained a Hold rating on ABB Ltd (0NX2 – Research Report), with a price target

In a report released today, Ben Hendrix from RBC Capital reiterated a Buy rating on HCA Healthcare (HCA – Research Report), with a price target

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $32.73 which represents a slight increase of $0.35 or 1.08% from the prior close of $32.38. The stock opened at $32.92 and touched a low of $32.

Wall Street analysts largely maintained bullish views on IBM (NYSE:IBM) after the tech giant's fourth-quarter results and outlook surpassed expectations. Shares of IBM jumped about 9% premarket on Thursday.

RBC Capital Markets adjusted their outlook on Lennox International (NYSE:LII), a global provider of climate control solutions. Analyst Deane Dray at RBC Capital increased the price target for Lennox International to $642 from the previous target of $617,

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the important fact that global interest in Canadian bonds remains high,

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the presidency. Morgan Stanley has notched a 17% gain. Investors have a dinner plate to choose from to explain the bullishness.

RBC Capital Markets analyst Ashish Sabadra reiterated the Outperform rating on MSCI Inc. (NYSE:MSCI) with a price forecast of $675. Yesterday, the firm reported fourth-quarter revenue growth of 7.7% year-on-year to $743.

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $142.0 and $165.0 for Johnson & Johnson, spanning the last three months. Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.